OrthoSpace develops and commercializes simple-to-implant biodegradable balloon systems for the orthopedic market. The company aims to create effective solutions for orthopedics that reduce pain and increase patients' range of motion while preserving bone and joint structures.
The company's InSpace is an alternative treatment for cases when the rotator cuff is deemed irreparable. The InSpace device, which is based on an implantable, biodegradable balloon system, is implanted in a minimally invasive procedure on an outpatient basis to help alleviate pain and shorten the rehabilitation period.
The balloon creates a space between the two bones where friction causes the most pain. Once the spacer is in place, there is no longer friction between the bones and pain is reduced. This reduction in pain enables the body to recuperate faster than it would undergoing comparable surgical treatments. In addition, implementation does not involve hospitalization.
The OrthoSpace InSpace has the CE mark and is being marketed in Europe. In the United States, the InSpace is currently approved for investigational use only.
South America, East Asia, Canada, United States, Israel, Europe, Southeast Asia